medline.ch Neurologie Multiple Sklerose

	Perspectives of participating neurologists and study nurses - Mixed-methods process evaluation of a web-based program for relapse management in multiple sclerosis (POWER@M2). Mult Scler Relat Disord Bremer L, Hickstein J, Wenzel L, Scheiderbauer J, de Loo MV, Rahn AC, Heesen C, Köpke S. PMID: 42551285 [PubMed - as supplied by publisher]
	Applying the 2024-revised McDonald criteria for multiple sclerosis using conventional diagnostic tools: a single-centre prospective cohort study in Germany. EClinicalMedicine Konen FF, Mahmoudi N, Albers LM, Arrambide G, Streichert AL, Haar M, Soldatov A, Bucak E, Jendretzky KF, Nay S, Grote-Levi L, Hegelmaier T, Trebst C, Schwenkenbecher P, Hümmert MW, Pawlitzki M, Sühs KW, Khalil M, Framme C, Petzold A, Meuth SG, Wattjes MP, Haghikia A, Montalban X, Renne J, Skripuletz T. PMID: 42549016 [PubMed]
	Case Report: Overlapping multiple sclerosis and neuropsychiatric systemic lupus erythematosus with positive MOG-IgG: a case initially misdiagnosed as depression. Front Immunol Wei W, Jin T, Zhang L, Sun Y, Xu Y, Hong X. PMID: 42548805 [PubMed - indexed for MEDLINE]
	Neural Stem Cells in Multiple Sclerosis: A Comprehensive Review of Preclinical and Clinical Evidence for CNS Repair and Translational Hurdles. Appl Biochem Biotechnol Razzaghi E, Azari A, Golchin A, Mihanfar A. PMID: 42547698 [PubMed - as supplied by publisher]
	Towards a biologically informed description of multiple sclerosis disease course - a roadmap for transition. Nat Rev Neurol Thompson AJ, Lublin FD, Rechtman L, Quinn J, Amato MP, Bebo B, Calabresi PA, Fiol J, Finlayson M, Hawton A, Kuhlmann T, Marrie RA, Moccia M, Montalban X, Panzara M, Smith K, Sormani MP, Strum J, Vickrey BG, Coetzee T, 2025 International Advisory Committee on Clinical Trials in Multiple Sclerosis. PMID: 42547548 [PubMed - as supplied by publisher]
	Chitinase-1 in cerebrospinal fluid and white matter injury in patients with progressive multiple sclerosis. J Neuroimmunol Talbot J, Højsgaard Chow H, Romme Christensen J, Ratzer R, Holm Hansen R, Buhelt S, Mahler MR, Lundell H, von Essen MR, Siebner HR, Kosa P, Bielekova B, Sellebjerg F. PMID: 42546452 [PubMed - as supplied by publisher]
	A Faster Way to Diagnose Multiple Sclerosis: The Central Vein Sign in Routine Clinical Practice. Neurol Clin Pract Gilmartin CGS, Paskin T, Clarke MA, De Dios Peréz B, Morgan P, Dineen RA, Evangelou N. PMID: 42546228 [PubMed - indexed for MEDLINE]
	Dysregulation of ferroptosis-related plasma biomarkers in treatment-free patients with relapsing-remitting multiple sclerosis in clinical remission: a case-control study. Acta Neurol Belg Nazari-Robati M, Shahouzehi B, Naiini MR. PMID: 42545622 [PubMed - as supplied by publisher]
	Clinical and economic impact on people with relapsing-remitting multiple sclerosis in the United States: a matched-cohort study. Curr Med Res Opin Greene N, Das AK, Hemim I, Chang E, Tarbox MH, Higuchi K. PMID: 42544916 [PubMed - as supplied by publisher]
	Testing the construct validity of real-world digital mobility outcomes in multiple sclerosis. Mult Scler Brittain G, Long M, Buckley E, Becker C, Buekers J, de Las Heras M, Armengol C, Koch S, Braun J, Caufield B, Comi G, Dalla Costa G, Frei A, Gassner H, Ionescu A, Leocani L, Rochester L, Rothhammer V, Singleton D, Stuerner KH, Paling D, Padmakumari Sivaraman Nair K, Majid A, Brichetto G, Vereijken B, Lanfranchi V, Jansen CP, Sutcliffe L, Del Din S, Neatrour I, Cereatti A, Maetzler W, Hansen C, Rooks D, Sharrack B, Garcia-Aymerich J. PMID: 42544006 [PubMed - as supplied by publisher]
	Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study. Mult Scler Nesbitt C, Sanfilippo P, Zhu C, Ozakbas S, Prat A, Girard M, Duquette P, Kalincik T, Roos I, Buzzard K, Skibina O, Foschi M, Surcinelli A, Lechner-Scott J, Patti F, Kermode AG, Fabis-Pedrini M, Carroll WM, Hodgkinson S, Grand'Maison F, Havrdova EK, Hradilek P, Habek M, Maimone D, Alroughani R, Vachova M, van Pesch V, Macdonell R, Spitaleri D, Khoury SJ, Gerlach O, de Gans K, McCombe P, Van Der Walt A, Butzkueven H, Jokubaitis V. PMID: 42543909 [PubMed - as supplied by publisher]
	Efficacy and safety of cannabinoids in the treatment of spasticity in multiple sclerosis: A systematic review of randomized clinical trials. Br J Clin Pharmacol Hamm-Buiar L, Gorski D, Kagueiama MH, Wiens A. PMID: 42543771 [PubMed - as supplied by publisher]
	Incidence and prevalence of multiple sclerosis in Qatar: A population-based study from 2016 to 2024. Mult Scler Relat Disord AbuAlrob MA, Khodair R, Ibrahim F, Hamid S, Suliman O, Zammar K, Abdelmoneim MS, Perkins JD, Canibano B. PMID: 42542074 [PubMed - as supplied by publisher]
	Impact of tobacco and alcohol consumption on disease progression and MRI in people with multiple sclerosis: results of the prospective cohort study NationMS. Ther Adv Neurol Disord Keller AM, Möhl A, Salmen A, Gold R, Renk P, Klotz L, Bittner S, Fleischer V, Paul F, Ruprecht K, Giglhuber K, Tumani H, Antony G, Zettl U, Meuth SG, Bayas A, Trebst C, Wildemann B, Then Bergh F, Kotz D, Heesen C. PMID: 42539872 [PubMed]
	Predictors of Multiple Sclerosis After Clinically Isolated Syndrome: A Systematic Review and Meta-Analysis. Eur J Neurol Zafra-Sierra MP, Ferreira-Atuesta C, Rodríguez DS, Gaitán J, Otero S, Tintoré M, Lublin F, Giovannoni G, Toro J, Reyes S. PMID: 42538767 [PubMed - indexed for MEDLINE]
	Lesion burden determines the incremental diagnostic value of intrathecal IgG oligoclonal bands synthesis in multiple sclerosis. J Neuroimmunol Mauceri VA, Di Mare D, Rinaldi F, Di Paola A, Zoccarato M, Gallo P, Perini P, Puthenparampil M. PMID: 42537512 [PubMed - as supplied by publisher]
	MSPEECH (multiple sclerosis monitoring through speech interaction in clinic and at home): a Living Lab study protocol for co-created, speech-based digital biomarkers in multiple sclerosis. Front Digit Health Lemkau T, Inojosa H, Dillenseger A, Tröger J, Hermann J, Linz N, Gilbert S, Ziemssen T. PMID: 42534930 [PubMed]
	Infusion-related reactions and premedication patterns in ublituximab-treated multiple sclerosis patients: a multicenter real-world study. Front Neurol Nourelden AZ, Scott PR, Hooshmand SI, Mazur I, Mada F, Ash T, Patel N, Rube J, Yarraguntla K, Deluca C, Yager-Stone P, Havens R, Wallin M, Memon AB. PMID: 42534927 [PubMed]
	Early Upper Limb Motor Impairment in Multiple Sclerosis Across EDSS Levels: A Case-Control Study. Brain Behav Blázquez-Fernández A, Marcos-Antón S, Estrada-Barranco C, Martín-Casas P, Ortiz-Gutiérrez RM, Jiménez-Antona C, Laguarta-Val S, Cano-de-la-Cuerda R. PMID: 42533673 [PubMed - indexed for MEDLINE]
	Comorbidities in multiple sclerosis: acquired hepatocerebral degeneration mimicking disease progression. Neurol Sci Einsiedler M, Polymeris A, Raptis N, Beyer A, Becker D, Krassenburg L, Panne I, Mahmutoglu MA, Lieb JM, Rüegg S, Derfuss T, Kuhle J. PMID: 42533190 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 44611

Seite 1 von 2231

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung